

1,401,923 filings since 2004 · latest accepted Nov 3, 2026, 5:27 PM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Nov 2, 2026 accepted 9:51 AM ET | ABVCABVC BIOPHARMA, INC. | 1.01Material agreement1.02Agreement terminated2.03New debt obligation3.02Unregistered equity sale5.07Shareholder vote7.01Reg FD disclosure | Document |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
Jul 2, 2026 accepted 4:01 PM ET | ABVCABVC BIOPHARMA, INC. | 4.01Auditor change | DocumentSEC ↗ |
Mar 3, 2026 accepted 4:14 PM ET | ABVCABVC BIOPHARMA, INC. | 2.02Earnings release4.02Non-reliance (restatement) | DocumentSEC ↗ |
Sep 12, 2025 accepted 7:16 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 4.01Auditor change | DocumentSEC ↗ |
May 14, 2025 accepted 8:30 AM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 3.01Delisting notice7.01Reg FD disclosure | DocumentSEC ↗ |
May 6, 2025 accepted 4:30 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 3.01Delisting notice | DocumentSEC ↗ |
May 2, 2025 accepted 4:30 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 4.02Non-reliance (restatement) | DocumentSEC ↗ |
Apr 30, 2025 accepted 4:30 PM ET | ABVCABVC BIOPHARMA, INC. | 3.01Delisting notice3.02Unregistered equity sale | DocumentSEC ↗ |
Apr 15, 2025 accepted 4:30 PM ET | ABVCABVC BIOPHARMA, INC. | 2.02Earnings release4.02Non-reliance (restatement)7.01Reg FD disclosure | DocumentSEC ↗ |
Jan 13, 2025 accepted 6:56 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 3.01Delisting notice7.01Reg FD disclosure | DocumentSEC ↗ |
Oct 18, 2024 accepted 5:23 PM ET | ABVCABVC BIOPHARMA, INC. | 4.01Auditor change | DocumentSEC ↗ |
Jul 12, 2024 accepted 4:05 PM ET | ABVCABVC BIOPHARMA, INC. | 3.01Delisting notice | DocumentSEC ↗ |
May 17, 2024 accepted 5:00 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 1.01Material agreement1.02Agreement terminated | DocumentSEC ↗ |
Aug 31, 2023 accepted 8:30 AM ET | ABVCABVC BIOPHARMA, INC. | 3.01Delisting notice | DocumentSEC ↗ |
Aug 9, 2023 accepted 5:00 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 3.01Delisting notice | DocumentSEC ↗ |
Jul 14, 2023 accepted 5:00 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 3.01Delisting notice | DocumentSEC ↗ |
May 26, 2023 accepted 4:31 PM ET | ABVCABVC BIOPHARMA, INC. | 3.01Delisting notice | DocumentSEC ↗ |
Feb 16, 2023 accepted 4:30 PM ET | ABVCABVC BIOPHARMA, INC. | 3.01Delisting notice | DocumentSEC ↗ |
Oct 21, 2022 accepted 4:30 PM ET | ABVCABVC BIOPHARMA, INC. | 4.01Auditor change | DocumentSEC ↗ |
Aug 22, 2022 accepted 4:30 PM ET | ABVCABVC BIOPHARMA, INC. | 3.01Delisting notice | DocumentSEC ↗ |
Mar 12, 2018 accepted 5:00 PM ET | ABVCABVC BIOPHARMA, INC. | 4.02Non-reliance (restatement) | DocumentSEC ↗ |
Nov 28, 2017 accepted 4:59 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 4.01Auditor change | DocumentSEC ↗ |
Nov 27, 2017 accepted 4:30 PM ET | ABVCABVC BIOPHARMA, INC. | 4.01Auditor change | DocumentSEC ↗ |
Feb 22, 2017 accepted 4:23 PM ET | ABVCABVC BIOPHARMA, INC. | 1.01Material agreement3.02Unregistered equity sale4.02Non-reliance (restatement) | DocumentSEC ↗ |
May 10, 2016 accepted 3:56 PM ET | ABVCABVC BIOPHARMA, INC. | 4.01Auditor change | DocumentSEC ↗ |
Mar 1, 2016 accepted 6:01 AM ET | ABVCABVC BIOPHARMA, INC. | 4.01Auditor change | DocumentSEC ↗ |
Feb 16, 2016 accepted 5:35 PM ET | ABVCABVC BIOPHARMA, INC. | 1.01Material agreement2.01Acquisition / disposition3.02Unregistered equity sale5.01Change in control5.02Officer / director change5.06Shell status change | DocumentSEC ↗ |
Dec 18, 2015 accepted 5:16 PM ET | ABVCABVC BIOPHARMA, INC. | 1.01Material agreement3.01Delisting notice5.01Change in control5.02Officer / director change | DocumentSEC ↗ |
Nov 6, 2014 accepted 2:40 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 4.01Auditor change | DocumentSEC ↗ |
Oct 31, 2014 accepted 2:46 PM ET | ABVCABVC BIOPHARMA, INC. | 4.01Auditor change | DocumentSEC ↗ |
Oct 24, 2014 accepted 3:42 PM ET | ABVCABVC BIOPHARMA, INC. | 1.02Agreement terminated1.03Bankruptcy2.01Acquisition / disposition2.02Earnings release5.01Change in control5.02Officer / director change8.01Other events | DocumentSEC ↗ |
May 16, 2013 accepted 11:00 AM ET | ABVCABVC BIOPHARMA, INC. | 1.03Bankruptcy | DocumentSEC ↗ |
Apr 3, 2013 accepted 2:39 PM ET | ABVCABVC BIOPHARMA, INC. | 1.03Bankruptcy | DocumentSEC ↗ |
Jan 23, 2013 accepted 3:51 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 4.01Auditor change | DocumentSEC ↗ |
Jan 10, 2013 accepted 10:47 AM ET | ABVCABVC BIOPHARMA, INC. | 4.01Auditor change8.01Other events | DocumentSEC ↗ |
Feb 6, 2012 accepted 2:25 PM ET | ABVCABVC BIOPHARMA, INC. | 4.01Auditor change | DocumentSEC ↗ |
Dec 8, 2010 accepted 10:16 AM ET | ABVCABVC BIOPHARMA, INC. | 2.04Debt acceleration | DocumentSEC ↗ |
Nov 20, 2009 accepted 3:36 PM ET | ABVCABVC BIOPHARMA, INC. | 1.02Agreement terminated | DocumentSEC ↗ |
Jul 29, 2009 accepted 2:29 PM ET | ABVCABVC BIOPHARMA, INC. | 1.02Agreement terminated | DocumentSEC ↗ |
Sep 8, 2008 accepted 2:46 PM ET | ABVCABVC BIOPHARMA, INC. | 1.01Material agreement2.04Debt acceleration | DocumentSEC ↗ |
Sep 3, 2008 accepted 1:24 PM ET | ABVCABVC BIOPHARMA, INC. | 2.04Debt acceleration | DocumentSEC ↗ |
Aug 29, 2008 accepted 5:30 PM ET | ABVCABVC BIOPHARMA, INC. | 1.01Material agreement3.02Unregistered equity sale3.03Holder rights modified5.01Change in control | DocumentSEC ↗ |
Aug 22, 2008 accepted 5:08 PM ET | ABVCABVC BIOPHARMA, INC. | 2.04Debt acceleration | DocumentSEC ↗ |
Sep 17, 2007 accepted 3:45 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 4.01Auditor change | DocumentSEC ↗ |
Aug 30, 2007 accepted 10:22 AM ET | ABVCABVC BIOPHARMA, INC. | 4.01Auditor change5.02Officer / director change | DocumentSEC ↗ |
Aug 9, 2007 accepted 11:11 AM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 4.01Auditor change | DocumentSEC ↗ |
Jul 30, 2007 accepted 1:20 PM ET | ABVCABVC BIOPHARMA, INC. | 1.01Material agreement3.02Unregistered equity sale4.01Auditor change5.01Change in control5.02Officer / director change5.03Bylaws / fiscal year5.06Shell status change | DocumentSEC ↗ |
Jan 6, 2006 accepted 4:30 PM ET | ABVCABVC BIOPHARMA, INC. | 8-K/A 4.01Auditor change | DocumentSEC ↗ |
Jan 6, 2006 accepted 11:30 AM ET | ABVCABVC BIOPHARMA, INC. | 4.01Auditor change | DocumentSEC ↗ |